1984
DOI: 10.1248/cpb.32.4130
|View full text |Cite
|
Sign up to set email alerts
|

Particle size dependency of dissolution rate and human bioavailability of phenytoin in powders and phenytoin-polyethylene glycol solid dispersions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

1993
1993
2016
2016

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(10 citation statements)
references
References 0 publications
0
10
0
Order By: Relevance
“…2,3) According to a few reports, however, the dissolution rate of phenytoin was improved by reducing its particle size, thereby increasing its concentration in blood to the desired level. [4][5][6] Reducing the particle size makes the increase of surface area and as a result of it, dissolution rate of drug increases according to the Nernst-Brunner and Levich modification of the Noyes-Whitney model of dissolution. 7,8) Solubility problem could be solved by reducing particle size to nanometer range.…”
mentioning
confidence: 99%
“…2,3) According to a few reports, however, the dissolution rate of phenytoin was improved by reducing its particle size, thereby increasing its concentration in blood to the desired level. [4][5][6] Reducing the particle size makes the increase of surface area and as a result of it, dissolution rate of drug increases according to the Nernst-Brunner and Levich modification of the Noyes-Whitney model of dissolution. 7,8) Solubility problem could be solved by reducing particle size to nanometer range.…”
mentioning
confidence: 99%
“…In the melting process, the molecular mobility of carrier is high enough to change the drug's incorporation 36 . A common adaptation to the melting phase consists of suspending the active drug in a previously melted carrier, instead of using both drug and carrier in the melted state, reducing, therefore, the process temperature .To cool and solidify the melted mixture, several processes such as ice bath agitation 37,38 , stainless steel thin layer spreading followed by a cold draught 39 , solidification on petri dishes at room temperature inside a dessicator 40 , spreading on plates placed over dry ice 41 , immersion in liquid nitrogen or stored in a dessicator 42,43 were used.…”
Section: Fig 4: Manufacturing Processes Used To Produce Solid Dispermentioning
confidence: 99%
“…n ) Calculated based on the AUC values of tablet and solution formulations assuming that Fa from latter one is 1 [48]. o ) Calculated based on the AUC 0-48 values of tablet formulation in fasted and fed states assuming that Fa from latter one is 1 ( Fa ¼ 0.58) and bioavailability of 59% [38] [41]. p ) Calculated based on the AUC of tablet formulation in the fasted and fed conditions assuming that Fa from latter one is 1 [46].…”
Section: General Absorption Equationmentioning
confidence: 99%